63 Regorafenib monotherapy for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Chemo-target Therapy

Regorafenib monotherapy for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Chemo-target Therapy
Chun-Li Wang
https://storage.unitedwebnetwork.com/files/1083/920ece8bd8a00fd75bcbdffa1516d9ba.pdf
Submission Deadline: 1 February 2025